Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors

Clinical trial NCT05002868 · COMPLETED

Trial details

NCT number: NCT05002868
Sponsor: Rhizen Pharmaceuticals SA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Extensive-stage Small-cell Lung Cancer Locally Advanced Breast Cancer Metastatic Breast Cancer Platinum-sensitive Ovarian Cancer Platinum-Sensitive Fallopian Tube Carcinoma Platinum-Sensitive Peritoneal Cancer

Start date: 2021-10-05
Primary completion: 2024-04-25
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.